• Most Popular
  • Most Shared

UPDATE 1-Schering-Plough hepatitis combo gets OK EU opinion

Mon Sep 24, 2007 9:38am EDT

Stocks

   

(Adds background)

BOSTON, Sept. 24 (Reuters) - Advisers to the European Commission have recommended approval of a combination hepatitis C therapy tested by Schering-Plough Corp. SGP.N to re-treat patients who have failed a previous round of therapy, the company said on Monday.

The Kenilworth, New Jersey-based drugmaker said the Committee for Medicinal Products for Human Use of the European Medicines Agency issued a positive opinion recommending approval of the combination of Schering-Plough's Peg-Intron and Rebetol, a standard treatment also known as ribavirin.

The opinion was based on results of a continuing clinical study involving 1,336 patients who failed previous treatments.

Interferon therapy is designed to boost the immune system. Schering-Plough's version, Peg-Intron, competes with Roche Holding AG's (ROG.VX) Pegasys. These drugs are the mainstay of hepatitis C treatment.

Peg-Intron is approved in the United States as a single agent treatment and for use in combination with Rebetol.

Schering-Plough said it tested the combination therapy in patients who had failed other interferon-based therapies. If approved the company said the combination would be the only available hepatitis C treatment in Europe indicated for prior treatment failures. (Reporting by Toni Clarke)



More from Reuters

Photo

U.S. probing if al Qaeda linked to airplane incident

WASHINGTON (Reuters) - The Obama administration said on Sunday it was investigating whether al Qaeda was involved in a Christmas Day attempt to blow up a passenger jet and sought to head off Republican attacks over its anti-terrorism measures. | Video

A Delta Airbus 330 airliner sits on a runway at Detroit Metropolitan Airport in Romulus, Michigan in this video grab made December 25, 2009. Credit: REUTERS/WDIV TV/Handout

The battle in mid-air

The attraction of bombing airliners means the aviation industry has to be constantly vigilant in its fight against attackers.  Full Article 

A caution sign is seen next to a stock board at the Australian Securities Exchange (ASX) in Sydney September 5, 2008. REUTERS/Daniel Munoz
Political Risk in 2010:

Don't say we didn't warn you

With the financial crisis (mostly) in the past, U.S. investors are eying a fresh start to the coming year. Here's a look at what speedbumps lie ahead.  Full Article